Clinical Trials Browser

Phase 1/2 × propranolol CR × Dermatologic × Clear all

NCT03384836 2025-07-02

Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

Phase 1/2 Suspended

Melanoma